• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

飞燕草素通过阻断Raf/丝裂原活化蛋白激酶激酶/细胞外信号调节激酶信号通路,减轻JB6 Cl41小鼠表皮细胞的肿瘤转化。

Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling.

作者信息

Kang Nam Joo, Lee Ki Won, Kwon Jung Yeon, Hwang Mun Kyung, Rogozin Evgeny A, Heo Yong-Seok, Bode Ann M, Lee Hyong Joo, Dong Zigang

机构信息

Hormel Institute, University of Minnesota, 801 16th Avenue Northeast, Austin, MN 55912, USA.

出版信息

Cancer Prev Res (Phila). 2008 Dec;1(7):522-31. doi: 10.1158/1940-6207.CAPR-08-0071.

DOI:10.1158/1940-6207.CAPR-08-0071
PMID:19139002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2832759/
Abstract

Recent studies suggest that anthocyanidins play a pivotal role in the chemopreventive effects of fruits and vegetables. However, the underlying molecular mechanisms and cellular targets remain unknown. Neoplastic transformation of cells and inflammation are considered to be major events contributing to carcinogenesis. Here, we report that delphinidin, a major dietary anthocyanidin, inhibits tumor promoter-induced transformation and cyclooxygenase-2 (COX-2) expression in JB6 promotion-sensitive mouse skin epidermal (JB6 P+) cells by directly targeting Raf and mitogen-activated protein kinase kinase (MEK). Delphinidin inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced neoplastic transformation and COX-2 expression at both the protein and transcriptional levels. The activation of activator protein-1 and nuclear factor-kappaB induced by TPA was dose dependently inhibited by delphinidin treatment. Delphinidin strongly suppressed Raf1 and MEK1 kinase activities and subsequently attenuated TPA-induced phosphorylation of MEK, extracellular signal-regulated kinase (ERK), p90RSK, and MSK. Although delphinidin suppressed ERK and c-Jun NH(2)-terminal kinase activities, it was more effective at inhibiting Raf1 or MEK1 activities. Pull-down and competition assays revealed that delphinidin binds with Raf1 or MEK1 noncompetitively with ATP. Delphinidin also dose dependently suppressed JB6 P+ cell transformation induced by epidermal growth factor and H-Ras, both of which are involved in the activation of Raf/MEK/ERK signaling. Together, these findings suggested that the targeted inhibition of Raf1 and MEK activities and COX-2 expression by delphinidin contribute to the chemopreventive potential of fruits and vegetables.

摘要

近期研究表明,花青素在水果和蔬菜的化学预防作用中起着关键作用。然而,其潜在的分子机制和细胞靶点仍不清楚。细胞的肿瘤转化和炎症被认为是致癌过程中的主要事件。在此,我们报告,膳食中主要的花青素飞燕草素,通过直接作用于Raf和丝裂原活化蛋白激酶激酶(MEK),抑制肿瘤启动子诱导的JB6促癌敏感小鼠皮肤表皮(JB6 P+)细胞的转化和环氧合酶-2(COX-2)表达。飞燕草素在蛋白质和转录水平上均抑制12-O-十四酰佛波醇-13-乙酸酯(TPA)诱导的肿瘤转化和COX-2表达。飞燕草素处理可剂量依赖性地抑制TPA诱导的活化蛋白-1和核因子-κB的激活。飞燕草素强烈抑制Raf1和MEK1激酶活性,随后减弱TPA诱导的MEK、细胞外信号调节激酶(ERK)、p90RSK和MSK的磷酸化。虽然飞燕草素抑制ERK和c-Jun氨基末端激酶活性,但它在抑制Raf1或MEK1活性方面更有效。下拉和竞争试验表明,飞燕草素与Raf1或MEK1的结合不与ATP竞争。飞燕草素还剂量依赖性地抑制表皮生长因子和H-Ras诱导的JB6 P+细胞转化,这两者都参与Raf/MEK/ERK信号的激活。总之,这些发现表明,飞燕草素对Raf1和MEK活性以及COX-2表达的靶向抑制有助于水果和蔬菜的化学预防潜力。

相似文献

1
Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling.飞燕草素通过阻断Raf/丝裂原活化蛋白激酶激酶/细胞外信号调节激酶信号通路,减轻JB6 Cl41小鼠表皮细胞的肿瘤转化。
Cancer Prev Res (Phila). 2008 Dec;1(7):522-31. doi: 10.1158/1940-6207.CAPR-08-0071.
2
Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.Raf和MEK蛋白激酶是槲皮素(红酒中的一种主要黄酮醇)化学预防作用的直接分子靶点。
Cancer Res. 2008 Feb 1;68(3):946-55. doi: 10.1158/0008-5472.CAN-07-3140.
3
Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway.雌马酚是大豆异黄酮黄豆苷元的一种代谢产物,它通过靶向MEK/ERK/p90RSK/激活蛋白-1信号通路来抑制肿瘤细胞转化。
J Biol Chem. 2007 Nov 9;282(45):32856-66. doi: 10.1074/jbc.M701459200. Epub 2007 Aug 27.
4
Cocoa procyanidins suppress transformation by inhibiting mitogen-activated protein kinase kinase.可可原花青素通过抑制丝裂原活化蛋白激酶激酶来抑制细胞转化。
J Biol Chem. 2008 Jul 25;283(30):20664-73. doi: 10.1074/jbc.M800263200. Epub 2008 Jun 2.
5
Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms.花青素抑制活化蛋白1活性和细胞转化:构效关系及分子机制
Carcinogenesis. 2004 Jan;25(1):29-36. doi: 10.1093/carcin/bgg184. Epub 2003 Sep 26.
6
Peonidin inhibits phorbol-ester-induced COX-2 expression and transformation in JB6 P+ cells by blocking phosphorylation of ERK-1 and -2.芍药色素通过阻断细胞外信号调节激酶1和2(ERK-1和ERK-2)的磷酸化来抑制佛波酯诱导的JB6 P+细胞中环氧合酶-2(COX-2)的表达和转化。
Ann N Y Acad Sci. 2007 Jan;1095:513-20. doi: 10.1196/annals.1397.055.
7
Cyanidin suppresses ultraviolet B-induced COX-2 expression in epidermal cells by targeting MKK4, MEK1, and Raf-1.矢车菊素通过靶向 MKK4、MEK1 和 Raf-1 抑制表皮细胞中 UVB 诱导的 COX-2 表达。
Biochem Pharmacol. 2010 May 15;79(10):1473-82. doi: 10.1016/j.bcp.2010.01.008. Epub 2010 Jan 21.
8
The resveratrol analogue 3,5,3',4',5'-pentahydroxy-trans-stilbene inhibits cell transformation via MEK.白藜芦醇类似物3,5,3',4',5'-五羟基反式芪通过MEK抑制细胞转化。
Int J Cancer. 2008 Dec 1;123(11):2487-96. doi: 10.1002/ijc.23830.
9
Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha.Fyn激酶是飞燕草素抑制肿瘤坏死因子-α诱导的环氧化酶-2表达的直接分子靶点。
Biochem Pharmacol. 2009 Apr 1;77(7):1213-22. doi: 10.1016/j.bcp.2008.12.021. Epub 2009 Jan 7.
10
5'-Nitro-indirubinoxime inhibits epidermal growth factor- and phorbol ester-induced AP-1 activity and cell transformation through inhibition of phosphorylation of Pin1.5'-硝基靛红肟通过抑制 Pin1 的磷酸化抑制表皮生长因子和佛波酯诱导的 AP-1 活性和细胞转化。
Mol Carcinog. 2011 Dec;50(12):961-71. doi: 10.1002/mc.20761. Epub 2011 Mar 11.

引用本文的文献

1
Arachidonic acid in aging: New roles for old players.衰老过程中的花生四烯酸:老物质的新作用。
J Adv Res. 2025 Apr;70:79-101. doi: 10.1016/j.jare.2024.05.003. Epub 2024 May 4.
2
Delphinidin and Its Glycosides' War on Cancer: Preclinical Perspectives.飞燕草素及其糖苷类化合物抗癌之战:临床前视角。
Int J Mol Sci. 2021 Oct 25;22(21):11500. doi: 10.3390/ijms222111500.
3
Delphinidin induces cell cycle arrest and apoptosis in HER-2 positive breast cancer cell lines by regulating the NF-κB and MAPK signaling pathways.矢车菊素通过调节NF-κB和MAPK信号通路诱导HER-2阳性乳腺癌细胞系的细胞周期停滞和凋亡。
Oncol Lett. 2021 Dec;22(6):832. doi: 10.3892/ol.2021.13093. Epub 2021 Oct 14.
4
Recent Updates on Marine Cancer-Preventive Compounds.海洋防癌化合物的最新研究进展
Mar Drugs. 2021 Sep 29;19(10):558. doi: 10.3390/md19100558.
5
Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention.类黄酮作为预防前列腺癌的表观遗传调节剂。
Nutrients. 2020 Apr 6;12(4):1010. doi: 10.3390/nu12041010.
6
EGCG overcomes gefitinib resistance by inhibiting autophagy and augmenting cell death through targeting ERK phosphorylation in NSCLC.表没食子儿茶素没食子酸酯(EGCG)通过抑制自噬和靶向非小细胞肺癌(NSCLC)中的细胞外调节蛋白激酶(ERK)磷酸化增强细胞死亡来克服吉非替尼耐药性。
Onco Targets Ther. 2019 Jul 26;12:6033-6043. doi: 10.2147/OTT.S209441. eCollection 2019.
7
Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells.岩藻黄质诱导小鼠皮肤 JB6 P+细胞发生表观遗传修饰、Nrf2 激活和阻断转化。
AAPS J. 2018 Feb 20;20(2):32. doi: 10.1208/s12248-018-0197-6.
8
Diet phytochemicals and cutaneous carcinoma chemoprevention: A review.饮食中的植物化学物质与皮肤癌化学预防:综述
Pharmacol Res. 2017 May;119:327-346. doi: 10.1016/j.phrs.2017.02.021. Epub 2017 Feb 24.
9
Effects of anthocyanins on the prevention and treatment of cancer.花青素对癌症防治的作用。
Br J Pharmacol. 2017 Jun;174(11):1226-1243. doi: 10.1111/bph.13627. Epub 2016 Oct 25.
10
Molecular docking analysis of known flavonoids as duel COX-2 inhibitors in the context of cancer.已知黄酮类化合物作为癌症背景下的双重COX-2抑制剂的分子对接分析
Bioinformation. 2015 Dec 31;11(12):543-9. doi: 10.6026/97320630011543. eCollection 2015.

本文引用的文献

1
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer.靶向Raf-MEK-ERK丝裂原活化蛋白激酶级联反应用于癌症治疗。
Oncogene. 2007 May 14;26(22):3291-310. doi: 10.1038/sj.onc.1210422.
2
Raf kinases: oncogenesis and drug discovery.Raf激酶:肿瘤发生与药物研发
Int J Cancer. 2006 Nov 15;119(10):2261-71. doi: 10.1002/ijc.22144.
3
Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature.索拉非尼(BAY 43-9006,多吉美),一种双靶点抑制剂,可作用于肿瘤细胞中的RAF/MEK/ERK通路以及肿瘤血管中的酪氨酸激酶VEGFR/PDGFR。
Methods Enzymol. 2006;407:597-612. doi: 10.1016/S0076-6879(05)07047-3.
4
Signal transduction pathways in cancer development and as targets for cancer prevention.癌症发展中的信号转导通路及其作为癌症预防的靶点。
Prog Nucleic Acid Res Mol Biol. 2005;79:237-97. doi: 10.1016/S0079-6603(04)79005-4.
5
Inhibition of epidermal growth factor-induced cell transformation and Akt activation by caffeine.咖啡因对表皮生长因子诱导的细胞转化和Akt激活的抑制作用。
Mol Carcinog. 2005 Sep;44(1):67-76. doi: 10.1002/mc.20120.
6
Recent progress in targeting the Raf/MEK/ERK pathway with inhibitors in cancer drug discovery.癌症药物研发中使用抑制剂靶向Raf/MEK/ERK信号通路的最新进展。
Curr Opin Pharmacol. 2005 Aug;5(4):350-6. doi: 10.1016/j.coph.2005.04.007.
7
Targeting the mitogen-activated protein kinase cascade to treat cancer.靶向丝裂原活化蛋白激酶级联反应以治疗癌症。
Nat Rev Cancer. 2004 Dec;4(12):937-47. doi: 10.1038/nrc1503.
8
Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.人类丝裂原活化蛋白激酶激酶1(MEK1)和MEK2的结构揭示了新型非竞争性激酶抑制作用。
Nat Struct Mol Biol. 2004 Dec;11(12):1192-7. doi: 10.1038/nsmb859. Epub 2004 Nov 14.
9
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.BAY 43 - 9006具有广谱口服抗肿瘤活性,作用于参与肿瘤进展和血管生成的RAF/MEK/ERK信号通路及受体酪氨酸激酶。
Cancer Res. 2004 Oct 1;64(19):7099-109. doi: 10.1158/0008-5472.CAN-04-1443.
10
Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2.表达人环氧化酶-2的MCF-7人乳腺肿瘤细胞的侵袭性和血管生成表型
Prostaglandins Other Lipid Mediat. 2004 Apr;73(3-4):249-64. doi: 10.1016/j.prostaglandins.2004.03.004.